Anti-IFNalpha [AIFN]
Ab00792-10.0
ApplicationsNeutralisation/Blocking
Product group Antibodies
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IFNalfa [AIFN]
- Delivery Days Customer7
- Application Supplier NoteAIFNalpha1bIgG01, the IgG1 version of the antibody, is able to cause downregulation of ISG15 and IFIT-1 expression ex vivo in PBMCs, induced by either recombinant IFNalpha1b or naiive IFNalpha from SLE patients sera. The antibody also reduces the total serum IgG and IgM antibody levels in a pristane-primed lupus-like mouse model. This neutralization occurs by out-competing IFNR2 for IFNalpha1b, which prevents the formation of the IFNAR2-IFNalpha interaction and the IFNalpha-mediated signaling pathway.
- ApplicationsNeutralisation/Blocking
- Applications SupplierNeutralize
- CertificationResearch Use Only
- Protein IDP01562
- Protein NameInterferon alpha-1/13
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203